Dalton Pharma Services and The Henry M. Jackson Foundation Announce a Services Agreement for the Advancement of Military Medicine

13-Oct-2011 - Canada

Dalton Pharma Services announced the company has entered into a Contract for Service with The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) to supply and provide sterile fill services for a cGMP grade capsule conjugate vaccine against Campylobacter jejuni developed by the Naval Medical Research Center (NMRC) and Prof. Mario Monteiro (University of Guelph).

Dalton will scale up the conjugation and purification process of a capsule-protein conjugate vaccine intended for use in Phase 1 human clinical trials conducted by NMRC.

“Our expertise and capabilities in conjugation chemistry, sterile API manufacturing and our strength in aseptic filling, solidified the manufacturing agreement," said Peter Pekos, President and CEO of Dalton. “Dalton is committed to supporting the efforts of the Navy and the University of Guelph for novel vaccine research and development.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances